Clinical Trial Update: Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update covering Phase 2 and Phase 3 evaluation of NTI164 for Autism Spectrum Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• NTI164

Snippet

Sponsor: Fenix Innovation Group | Conditions: Autism Spectrum Disorder | Phase 2, Phase 3 | Status: UNKNOWN